Medico Remedies Limited (BOM:540937)
India
· Delayed Price · Currency is INR | Market Cap | 3.38B |
| Revenue (ttm) | 1.91B |
| Net Income (ttm) | 115.99M |
| Shares Out | 82.98M |
| EPS (ttm) | 1.40 |
| PE Ratio | 29.13 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 8,234 |
| Average Volume | 15,181 |
| Open | 40.35 |
| Previous Close | 41.25 |
| Day's Range | 40.00 - 42.00 |
| 52-Week Range | 31.00 - 59.00 |
| Beta | 0.40 |
| RSI | 52.11 |
| Earnings Date | May 30, 2026 |
About Medico Remedies
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster... [Read more]
Financial Performance
In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.
Financial StatementsNews
Medico Remedies shares surge nearly 5% after winning $1.78 million order from Turkmenistan government
Shares of Medico Remedies Ltd jumped 4.91% to ₹51.50 in early Tuesday trade after the company announced securing a significant...